InSightec Receives FDA Approval To Begin Phase I Parkinson’s Trial



InSightec Receives FDA Approval to Begin Phase I Parkinson’s Trial (via PR Newswire)

TIRAT CARMEL, Israel, August 20, 2012 /PRNewswire/ — InSightec Ltd, the global leader in MR guided Focused Ultrasound (MRgFUS), announced that it has received approval from the US Food and Drug Administration (FDA) to begin a Phase I clinical trial evaluating the use of its ExAblate® Neuro system…